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Abstract
Background: Babesia canis infection induces a marked acute phase response (APR)
that might be associated with alteration in lipid and lipoprotein metabolism and dis-
ease prognosis.
Hypothesis: Dogs with B. canis-induced APR develop dyslipidemia with altered lipo-
protein concentration and morphology.
Animals: Twenty-nine client-owned dogs with acute B. canis infection and 10 clini-
cally healthy control dogs.
Methods: Observational cross-sectional study. Serum amyloid A (SAA) was measured
using ELISA. Cholesterol, phospholipids, and triglycerides were determined biochemi-
cally. Lipoproteins were separated using agarose gel electrophoresis. Lipoprotein
diameter was assessed by polyacrylamide gradient gel electrophoresis; correlation
with ApoA-1 (radioimmunoassay) and SAA was determined.
Results: Dogs with B. canis infection had a marked APR (median SAA, 168.3 μg/mL;
range, 98.1-716.2 μg/mL) compared with controls (3.2 μg/mL, 2.0-4.2 μg/mL) (P < .001).
Dogs with B. canis infection had significantly lower median cholesterol (4.79 mmol/L,
1.89-7.64 mmol/L versus 6.15 mmol/L, 4.2-7.4 mmol/L) (P = .02), phospholipid
(4.64 mmol/L, 2.6-6.6 mmol/L versus 5.72 mmol/L, 4.68-7.0 mmol/L) (P = .02), and
α-lipoproteins (77.5%, 27.7%-93.5% versus 89.2%, 75.1%-93.5%) (P = .04), and higher
Abbreviations: ApoA-1, apolipoprotein A-1; APR, acute phase response; CETP, cholesterol ester transfer protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LPS,
lipopolysaccharide; PAGGE, polyacrylamide gradient gel electrophoresis; PCR, polymerase chain reaction; SAA, serum amyloid A; SR-B1, scavenger receptor, class B type 1; TRL, triglyceride-rich
lipoproteins; VLDL, very low-density lipoprotein.
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ApoA-1 (1.36 U, 0.8-2.56 U versus 0.95 U, 0.73-1.54 U) concentrations (P = .02).
Serum amyloid A correlated with high-density lipoproteins (HDLs) diameter (rho = .43;
P = .03) and ApoA-1 (rho = .63, P < .001).
Conclusions and Clinical Importance:Major changes associated with B. canis-induced
APR in dogs are related to concentration, composition, and morphology of HDL parti-
cles pointing to an altered reverse cholesterol transport. Parallel ApoA-1 and SAA
concentration increase is a unique still unexplained pathophysiological finding.
K E YWORD S
acute phase response, apolipoprotein A-1, high-density lipoprotein, lipoprotein diameter, serum
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1 | INTRODUCTION
The acute phase response (APR) is induced by tissue injury and
governed by a network of neuro-immuno-humoral signals that enable
rapid adaptation, elimination of harmful agents, and repair of damaged
tissue. One of the best described markers of an APR is an increase in
serum concentrations of acute phase proteins, such as serum amyloid
A (SAA). Acute phase responses also induce alterations in lipid metab-
olism that can lead to important changes in plasma lipids (cholesterol,
phospholipids, and triglycerides) and in the concentration, morphology
(diameter), and composition of lipoproteins.1 Some changes, such as a
decrease in high-density lipoprotein (HDL)-cholesterol, are related to
poor prognosis and death in septic humans and rodents.2
In humans and rodents, the APR is characterized not only by a
decrease in HDL, but also by a decrease in serum apolipoprotein (Apo)
A-1, the main apoprotein of HDL, suggesting altered reverse choles-
terol transport.3 Reverse cholesterol transport is a multistep process
leading to cholesterol transfer from peripheral tissues to the liver,
where uptake is mediated by the scavenger receptor, class B type
1 (SR-B1).1 ApoA-1 is indispensable for cholesterol efflux and esterifi-
cation, and for the remodeling of HDL particles.4 Furthermore, in acute
inflammation, HDL becomes enriched with SAA, resulting in further
modification of its morphology and diameter.5,6 The overall conse-
quence of an APR is decreased cholesterol efflux, altered HDL mor-
phology, and decreased cholesterol uptake through SR-BI in the liver.1
The influence of the APR on lipids and lipoproteins in dogs is
poorly understood. In dogs, the majority of serum cholesterol is con-
tained within HDL and involved in reverse cholesterol transport.7
Canine HDL particles form distinct α1 and α2 bands in electrophoretic
gels that correspond quantitatively to HDL-2 and HDL-1.8,9 Dogs lack
cholesterol ester transfer protein (CETP) activity, which in humans is
involved in transferring cholesteryl esters from HDL to low-density
lipoproteins (LDLs).10 These species differences might affect changes
in lipids and lipoproteins in dogs with inflammatory disease.
Babesia canis causes an important tick-borne disease that induces a
typical APR in dogs, with a major increase in SAA.11 Total cholesterol and
HDL-cholesterol levels are lower at the time of presentation than after
treatment with imidocarb-dipropionate,12 and ApoA-1 concentration is
higher in dogs with acute babesiosis.13 However, in those studies, the
method used for HDL cholesterol was not recommended for use with
canine serum,14 and the ApoA-1 results, obtained via mass spectrometry,
were unusual and unexplained. Furthermore, changes in lipids and lipo-
proteins have not yet been investigated in conjunction with SAA levels in
dogs with babesiosis, nor have changes in lipoprotein electrophoretic
patterns or lipoprotein morphology been examined.
We hypothesized that dogs with B. canis-induced APR develop
dyslipidemia with altered lipoprotein concentration and morphology,
compared with healthy dogs. Our aims were to (1) measure serum
lipids, SAA and ApoA-1 concentrations concurrently in dogs with
acute B. canis infection and to compare the results with those in clini-
cally healthy controls; (2) evaluate differences in lipoprotein types via
electrophoresis; and (3) evaluate lipoprotein diameter and its correla-
tion with SAA and ApoA-1 concentrations.
2 | MATERIALS AND METHODS
2.1 | Animals and samples
This observational cross-sectional study was conducted on dogs with
a confirmed diagnosis of B. canis infection presented in March and
April 2015 (the primary season for tick-borne disease) to a private vet-
erinary practice in a suburban Belgrade (Serbia) municipality that is
endemic for B. canis. Criteria for inclusion were: (1) acute onset of clin-
ical signs consistent with Babesia sp. infection (24-48 hours of anorexia,
fever, lethargy, pale or icteric mucous membranes and thrombocytope-
nia, leukopenia, and moderate anemia); (2) large Babesia organisms
observed in thin blood smears stained with a Romanowsky stain (BioDiff,
BioGnost, Zagreb, Croatia); (3) B. canis-positive polymerase chain reac-
tion (PCR; Tick/Vector Comprehensive RealPCR Panel Canine, IDEXX
Laboratories, Westbrook, Maine); and (4) negative serology for Dirofilaria
immitis, Ehrlichia sp., Anaplasma sp., and Borrelia sp. (SNAP 4Dx Plus,
IDEXX Laboratories). Dogs with visible wounds, neoplasia, and clinical
signs or diagnoses of ectoparasites, allergies, and endocrinopathies were
excluded. After blood collection and laboratory diagnostics, all dogs
received a standard single SC dose of imidocarb-dipropionate (6.6 mg/kg
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of body weight). All dogs were monitored for 15 days and the outcome
(died or recovered)was recorded.
Control dogs were owned by staff members at the Faculty of
Veterinary Medicine, University of Belgrade, Serbia. The dogs were
determined to be clinically healthy based on physical examination and
had no history of B. canis infection, negative results for Babesia by
blood smear examination and PCR, and negative results for other
organisms (SNAP 4Dx Plus, IDEXX Laboratories). Blood was collected
as part of a health check before routine neutering.
Residual serum samples collected for routine laboratory diagnostic
testing were used for all biochemical analyses. Blood samples were col-
lected from the cephalic vein, placed in evacuated glass tubes without
anticoagulant (Vacutainer, BectonDickinson, Franklin Lakes, New Jersey)
and centrifuged at 1500g for 10minutes. Serumwas harvested, placed in
Eppendorf tubes, and stored at−20C for up to 60 days until analysis.
All dog owners provided signed informed consent that the residual
blood and serum samples obtained for diagnostic purposes could be
used for a scientific study. The Ethical Committee of the Faculty of
Veterinary Medicine, University of Belgrade, approved this study, and
permission was obtained according to the Law for Animal Welfare from
the Ministry of Agriculture and Environmental Protection, Republic of
Serbia (permission number 323-07-03455/2015-05/3).
2.2 | Serum amyloid A as an indicator of the APR
Serum amyloid A concentration was determined using a solid sand-
wich ELISA that was previously validated for dogs (Tridelta Development
Ltd, Maynooth, County Kildare, Ireland).15 The intra-assay precision of
the assay is <10% and the detection limit is 0.8 μg/mL. Absorbance was
measured in microtiter plates on an ELISA plate reader (Elx800, Biotek
Instruments, Highland Park, Winooski, Vermont) at 450 nm.
2.3 | Cholesterol, triglycerides, and phospholipid
analysis
Serum was analyzed for total cholesterol and triglycerides, using rou-
tine clinical biochemistry kits according to the manufacturer's instruc-
tions (CHSL-0507 and TGML-0517, ELITech Clinical Systems, Sées,
France) on a Technicon RA-XT automated biochemistry analyzer
(Bayer Diagnostics, Swords, Co, Dublin, Ireland). Manufacturer controls
were used (CONT 0060 and CONT0061 ELITech Clinical Systems).
Total serum phospholipid concentration was determined by the method
of Zilversmit and Davis.16 Standard solution of KH2PO4 was prepared
for use as a control (PO662, Sigma-Aldrich Chemie, Germany).
2.4 | Complete blood count and biochemistry
analysis
Complete blood counts were done on an impedance-based hematol-
ogy analyzer (Abacus Junior Vet, Diatron, Vienna, Austria) within
2 hours of sampling. Total protein, albumin, glucose, urea nitrogen
and creatinine concentrations and alanine-aminotransferase (ALT),
aspartate-aminotransferase (AST), and alkaline phosphatase (ALP)
activities were measured using routine clinical biochemistry kits according
to the manufacturer's instructions (Elitech, Puteaux, France) on a
Technicon RA-XT automated biochemistry analyzer (Bayer).
2.5 | Serum lipoprotein electrophoresis
Serum lipoproteins were separated by commercial agarose gel electro-
phoresis and stained with Fat Red 7B according to manufacturer
guidelines (SAS Lipoprotein, Helena Laboratories, Beaumont, Texas).
Canine lipoproteins separate into the following bands based on migra-
tion distance in the gel: α1- (HDL-2), α2- (HDL-1), pre-β (very-low-
density lipoproteins [VLDL]), and β (LDL). Because pre-β and β bands
are difficult to distinguish in dogs, they were combined and reported
as triglyceride-rich lipoproteins (TRL).17
Within-run (10 replicates of the same sample on a single gel) and
between-run (a single sample run on 10 different gels) precision for rel-
ative lipoprotein concentrations was tested. Within-run and between-
run precision for TRL was 6.5% and 12.6%, respectively; within-run and
between-run precision for α-lipoproteins was 7.9% and 11.3%, respec-
tively. Densitometry was performed by scanning the gels (Epson Per-
fection V800 Scanner, Seico Epson Corp., Indonesia) and calculating
the relative lipoprotein concentration in each band as a percentage of
the optical absorbance of that fraction (TotalLab TL120, Nonlinear
Dynamics Ltd, Newcastle, UK). Agreement regarding the position of
bands was determined by consensus of 3 of the authors (Z. Milanovic,
A. Ilic Božovic, and M. Kovacevic Filipovic). Absolute concentrations
of lipoproteins were not determined because according to the manu-
facturer (Helena Laboratories), the lipid stain has a greater affinity
for triglycerides and cholesterol esters than for free cholesterol and
phospholipids. The maximal migration distance of α-lipoprotein bands
in control dogs was measured and the average value was used to nor-
malize maximal migration distances for all samples, including controls.
2.6 | Lipoprotein morphology (diameter)
The diameter of HDL and TRL particles was determined by polyacryl-
amide gradient gel electrophoresis (PAGGE) with a 3%-31% gradient.
Gels were prepared using a Hoefer SE 675 system (Amersham Pharmacia
Biotech, Vienna, Austria) for vertical electrophoresis (Hoefer SE 600 Ruby
system, Amersham Pharmacia Biotech). Electrophoresis time and voltage
were 13 minutes at 60 V, followed by 20 minutes at 170 V, and 20 hours
at 200 V. Gels were stained with Sudan Black B for lipids. Calibration
curves for determining the diameter of HDL and TRL particles were
prepared using carboxylated polystyrene microsphere beads (40 nm
diameter) and proteins with high molecular weights: thyroglobulin
(17.0 nm diameter), ferritin (12.2 nm), lactate dehydrogenase (8.4 nm),
and albumin (7.1 nm). Gels were scanned with Image Scanner III
(Amersham Pharmacia Biotech) and the Magic Scan software (version
4.6;1999; UMAX Data Systems, Inc, Fremont, California). Gels were
analyzed using Image Quant software (version 5.2; 1999; Molecular
Dynamics, Sunnyvale, California) as previously described.18 Briefly, the
diameter of the most prominent peak in the HDL region of each scan,
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as determined by the software, was designated as the dominant HDL
diameter (nm) and used for statistical analysis.18
2.7 | Apolipoprotein A-1 radioimmunoassay
Serum ApoA-1 concentration was determined using a radioimmunoas-
say as described previously, with minor modifications.19 Polystyrene
star tubes (Maxisorb Thermo Scientific, Denmark) were coated with
ApoA-1 rabbit polyclonal antibody (0.5 μg/tube, sc-30089, Santa Cruz
Biotechnology, Santa Cruz, California) in 0.05 M phosphate buffer,
pH 7.2-7.4 with 0.15 M NaCl (PBS) (Merck, Germany) and incubated at
4C overnight for antibody adsorption. After incubation, the tubes were
rinsed with PBS and uncoated tube sites were blocked with 1% bovine
serum albumin in PBS for 2 hours at 37C. After blocking, tubes were
again rinsed with PBS. Antibody radiolabeling with I125 was done by
the method of Hunter and Greenwood20 using 0.025 mg of ApoA-1
antibody and 0.5 mCi of I125 (Institute for Isotopes Co, Ltd, Budapest,
Hungary). Canine serum samples were diluted (1:2) in PBS containing
0.5% casein sodium salt from bovine milk (Sigma-Aldrich Chemie).
All samples (100 μL) were incubated with 100 μL of radiolabeled
ApoA-1 antibodies (5 × 105 cpm/tube) overnight at room tempera-
ture (RT, 21C-23C) in antibody-coated tubes. After incubation, the
tubes were rinsed, and bound radioactivity was measured in a Wizard
1470 Automatic γ-counter (PerkinElmer, Inc, Wellesley, Massachu-
setts). The concentration of ApoA-1 in canine serum samples was
expressed in arbitrary units (U) obtained by normalizing the actual
cpm/tube with the average cpm/tube of control samples.
2.8 | Statistical analysis
Data were analyzed using the MedCalc statistical software (version
16.2.1, Ostend, Belgium). Kolmogorov-Smirnov testing indicated the
data were not normally distributed; therefore, differences between
infected and control dogs were evaluated using the Mann-Whitney
test and data reported as median and range (minimum-maximum).
A P value of <.05 was considered significant. Spearman's rank corre-
lation coefficients (rho) were determined to assess the correlation
between SAA and ApoA-1 with HDL diameter and to assess the
correlation between SAA and ApoA-1 levels.
3 | RESULTS
Twenty-nine dogs met the inclusion criteria for acute B. canis infec-
tion. The group consisted of 14 male and 15 female dogs of various
breeds and with a median age of 3 (1–13) years. The clinical outcome
for all of the dogs was full recovery (none of the dogs died). Control
dogs consisted of 5 male and 5 female dogs with a median age of
3 (1–6) years. There was no significant difference in sex ratio or age
between infected and control groups. Dogs with acute B. canis infec-
tion had been anorexic for 24-48 hours, with a median rectal temper-
ature of 40.1C (range, 39.1C-41.2C), tachycardia, and nonpalpable
spleen; lymphadenomegaly was not observed.
Dogs with acute B. canis infection had significantly lower hemato-
crit, neutrophil, lymphocyte, and platelet counts compared with con-
trol dogs (Table 1). Based on reference limits used in our laboratory,
TABLE 1 Hematologic and serum biochemical results (median, minimum, and maximum values) in dogs with acute Babesia canis infection at
the time of presentation, as compared with clinically healthy control dogs
Analyte B. canis-infected (n = 29) Control (n = 10) Reference intervala Pb
RBC (×1012/L) 5.6 (1.4-7.5) 6.7 (5.9-7.5) 5.5-8.5 .03
HGB (g/L) 135 (33-180) 163 (136-181) 120-180 .05
HCT (%) 35.0 (9.0-46.4) 45.2 (37.0-52.0) 37.0-55.0 .008
Total WBC (×109/L) 5.7 (2.3-32.8) 10.5 (6.4-13.9) 6.0-17.0 .01
NEUT (×109/L) 4.5 (1.2-27.4) 9.0 (3.6-11.5) 3.0-12.0 .02
LYM (×109/L) 0.99 (0.34-4.85) 3.60 (1.00-3.79) 1.0-4.8 .01
PLT (×109/L) 46 (20-556) 333 (233-433) 200-500 .001
Total protein (g/L) 60 (40-97) 55 (54-70) 54-75 NSD
Albumin (g/L) 29 (21-38) 29 (25-31) 23-31 NSD
Globulins (g/L) 38 (17-69) 22 (20-32) 16-36 NSD
Glucose (mmol/L) 5.2 (3.2-8.4) 5.2 (4.5-6.1) 4.2-6.6 NSD
ALT (U/L) 37.5 (13-264) 45.5 (30-61) 10-109 NSD
AST (U/L) 48 (13-197) 18 (14-39) 13-60 .02
ALP (U/L) 163 (17-871) 54 (34-77) 11-114 .008
Creatinine (μmol/L) 129.0 (73.1-176.7) 92.4 (78.7-129.4) 54.0-150.0 .04
Urea (mmol/L) 7.3 (3.6-13.0) 5.7 (3.8-7.2) 2.9-10.0 .007
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HCT, hematocrit; HGB, hemoglobin;
LYM, lymphocytes; NEUT, segmented neutrophils; NSD, not significantly different; PLT, platelets; RBC, red blood cells; WBC, white blood cells.
aReference intervals are from the clinical laboratory in the Faculty of Veterinary Medicine, University of Belgrade, Serbia.
bSignificant differences (P < .05) between infected and control groups (Mann-Whitney test).
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dogs with B. canis infection had anemia (18/29), leukopenia (17/29),
leukocytosis (1/29), lymphopenia (16/29), lymphocytosis (1/29), thrombo-
cytopenia (26/29), and thrombocytosis (1/29). Infected dogs also had sig-
nificantly higher serum AST and ALP activities and creatinine and urea
concentrations compared with control dogs (Table 1). Dogs with B. canis
infection had hyperproteinemia (5/29), hypoproteinemia (10/29), hyper-
albuminemia (13/29), hypoalbuminemia (4/29), hyperglobulinemia (8/29),
hyperglycemia (4/29), hypoglycemia (8/29), azotemia (6/29), and
increased ALT (2/29), AST (12/29), and ALP (20/29) activities.
All dogs with B. canis infection had a strong APR based on a signif-
icant increase in SAA concentration (median, 168.3 μg/mL; range,
98.1-716.2 μg/mL) compared with that of control dogs (3.2 μg/mL,
2.0-4.2 μg/mL; P < .001) (Figure 1).
Dogs with B. canis infection had significantly lower concentrations
of total cholesterol and phospholipids compared with control dogs,
whereas triglyceride concentration did not differ (Figure 2). Control dogs
had clearly distinguishable lipoprotein bands for TRL, α2-lipoproteins
(HDL-1), and α1-lipoproteins (HDL-2) (Figure 3A). Twenty of 29 (69%)
dogs with B. canis infection lacked a separate HDL-2 band, with indis-
tinct separation of α2- and α1-lipoproteins. The maximal migration dis-
tance of α-lipoprotein bands was shorter in dogs infected with B. canis
(median, 0.90; range, 0.82-1.02), compared with control dogs (median,
1.02; range, 0.94-1.02; P = .002) (Figure 3B). Dogs with B. canis infection
had lower relative concentrations of HDL compared with healthy con-
trols, but relative TRL concentrations did not differ (Figure 3C).
Triglyceride-rich lipoprotein and HDL regions on PAGGE were
separated by narrow distinct band(s) previously identified as α2-mac-
roglobulin21 (Figure 4A). Dogs with B. canis infection had an accumu-
lation of larger HDL particles in the region between thyroglobulin
(17 nm) and ferritin (12.2 nm) (Figure 4A). The dominant TRL diame-
ter did not differ between infected and control dogs, whereas the
dominant HDL diameter was significantly larger in dogs with B. canis
infection (Figure 4B). Apolipoprotein A-1 concentration was signifi-
cantly higher in dogs with B. canis as compared with control dogs
(Figure 5). The dominant HDL diameter was positively correlated with
SAA concentration (rho = .43; P = .03), but not with ApoA-1 concentra-
tion (rho = .36; P = .06). There was a significant positive correlation
between SAA and ApoA-1 concentrations (rho = .63, P < .001).
4 | DISCUSSION
Patterns of lipids and lipoproteins in dogs with acute B. canis infection
differed significantly from those in clinically healthy dogs. Decreased
cholesterol and phospholipid concentrations, loss of HDL-2, and an
increased dominant diameter of HDL particles were consistent with
APR-induced changes in lipid metabolism and lipoprotein morphology,
as described in humans and rodents. These findings support decreased
reverse cholesterol transport as well as altered HDL morphology, possi-
bly because of enrichment with SAA. Unlike in other species, ApoA-1
concentrations were increased in dogs with B. canis-induced APR.
Further, triglyceride and TRL concentrations were unaffected, in con-
trast to previous findings in dogs with B. canis infection. These results
confirm and expand upon our understanding of altered lipid metabolism
in dogs with B. canis-induced APR, which might serve as a model for
lipid alterations in dogs with acute inflammation.
High-density lipoprotein is a major carrier of free and esterified
cholesterol and is also rich in phospholipids in healthy dogs,7 such that
the lack of HDL-2 in dogs with B. canis infection likely resulted in the
lower serum total cholesterol and phospholipid concentrations in the
present study. Low concentration of HDL-cholesterol occurs in dogs
with babesiosis,12,22 but the specific HDL type was not determined.
Cattle with acute B. bovis infection have decreased total cholesterol
concentration and a relative decrease in α-lipoproteins (HDL).23
People infected with Babesia also have decreased HDL concentrations.24
F IGURE 1 Serum amyloid A (SAA) concentration in dogs
with acute Babesia canis infection (n = 29) indicate a major acute phase
response, as compared with control dogs (n = 10). Boxes indicate the
lower to upper quartile (25th-75th percentile) and median value.
Whiskers extend to minimum and maximum values, with outliers shown
as individual points (***P < .001)
F IGURE 2 Concentrations of serum total cholesterol (Chol),
phospholipids (PL), and triglycerides (TG) in dogs with Babesia canis
infection and an acute phase response (n = 29) and in control dogs
(n = 10). Boxes indicate the lower to upper quartile (25th-75th percentile)
and median value. Whiskers extend to minimum and maximum values,
with outliers shown as individual points (*P = .02 for Chol, *P = .02 for PL)
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Our results confirmed that HDL-2 was decreased concurrent with high
SAA levels. One potential mechanism of decreased HDL in acute
inflammation is increased endothelial lipoprotein lipase expression,
which increases the hydrolysis of phospholipids and, in humans, leads
to the catabolism and subsequent decrease of HDL in an APR.25,26
Canine babesiosis increases cortisol and insulin concentration and
decreases thyroid hormone concentration.27,28 Theoretically, these
changes would be expected to induce hypercholesterolemia. How-
ever, low normal cholesterol concentration was observed in dogs
with B. canis infection in the present study, suggesting that increased
utilization of cholesterol in cortisol synthesis may have contributed
at least partly to lower cholesterol and HDL values.
The loss of distinctly separateHDL-1 andHDL-2 bands in lipoprotein
electrophoresis in dogs with B. canis-induced APR was consistent with
the alteration of HDL composition and an increase in the dominant HDL
diameter, as assessed by PAGGE. Increased HDL diameter has been
demonstrated repeatedly in vitro and in vivo in humans and mice with an
APR, always in association with increases in SAA concentration.5,6,29,30
F IGURE 3 Representative lipoprotein (Lp) electrophoretic patterns on agarose gel for A, a control dog and B, a dog with Babesia canis
infection, and C, the relative concentrations of triglyceride-rich lipoproteins (TRL) and high-density lipoproteins (HDL) in infected and control
dogs. A, Control dogs have distinct peaks for TRL, HDL-1, and HDL-2. B, Dogs with B. canis infection and an acute phase response have indistinct
separation between HDL-1 and HDL-2 and an overall shorter migration distance for all lipoproteins. Note the shorter migration distance of
lipoproteins (150th notch on the scale) in the infected dog as compared with the clinically healthy dog (200th notch on the scale). C, Dogs with
B. canis infection have a significantly lower relative HDL concentration compared with control dogs (*P = .04). Boxes indicate the lower to upper
quartile (25th-75th percentile) and median value. Whiskers extend to minimum and maximum values, with outliers shown as individual points
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Indeed, we demonstrated a modest but significant positive correlation
between the concentration of SAA and HDL diameter in the dogs with
B. canis-induced APR. During an APR in bovines other lipophilic serum
proteins are also bound to HDL particles.31 In particular, hemolysis, the
major cause of anemia in B. canis infection, can influence morphology of
HDL through the binding of free hemoglobin and haptoglobin.32
Another potential contribution to expansion of HDL diameter in
dogs with an APR is the lack of adequate HDL remodeling in the liver.
In dogs, 60% of HDL cholesteryl esters are removed from the plasma
through selective uptake by the liver via SR-B1.33 In humans and mice
with APRs, both hepatic lipase and SR-B1 are downregulated.34 Based
on investigations in humans using nuclear magnetic resonance, an
APR results in fewer small- and medium-sized HDL particles, with no
change (and hence a relative increase) in large HDL particles.35 Thus,
the decrease in smaller HDL-2 particles in dogs with B. canis-induced
APR may have resulted from decreased HDL-2 formation because of
altered hepatic lipase and SR-B1 function and/or increased HDL-2
catabolism by endothelial lipase.
In primates and rodents, decreased synthesis or increased catabo-
lism of ApoA-1 in association with increased SAA synthesis has led to
the conclusion by others that the 2 molecules are reciprocally regu-
lated by inflammation.3,36 Unexpectedly, dogs with B. canis-induced
APR and loss of HDL-2 in our study had higher relative ApoA-1 con-
centrations than control dogs. These results confirm those in a recent
study of dogs with babesiosis (in which ApoA-1 was measured using
mass spectrometry),13 but contrast with those in most other species
and types of inflammation, including dogs with Leishmania infection37
and children with malaria (Plasmodium falciparum),38 in which ApoA-1
values decrease together with decreased cholesterol values. in vitro
studies show that binding of SAA to HDL leads to physical displace-
ment of ApoA-1 from HDL particles.5,39 Nevertheless, expression of
SAA in the absence of inflammation does not decrease ApoA-1 levels
in transgenic mice.40 People homozygous for CETP mutations have
increased ApoA-1 levels, but in conjunction with increased HDL cho-
lesterol.41 Thus, the mechanism of increased ApoA-1 in dogs with
B. canis remains uncertain and may be species- or disease-specific.
Increased ApoA-1 in dogs with B. canis infection also might be the
F IGURE 4 Diameter of triglyceride-rich lipoproteins (TRL) and high-density liproproteins (HDL) on polyacrylamide gradient gel electrophoresis
(PAGGE). A, Polyacrylamide gradient gel electrophoresis stained with Sudan Black B for lipids. Control dogs (lanes 1 and 2), dogs with Babesia canis
infection (lanes 3 and 4), and ladder proteins (lane 5; LDH indicates lactate dehydrogenase). Note that B. canis-infected dogs have larger lipoproteins
in the HDL region between thyroglobulin and ferritin; also note the difference between control and infected dogs in the narrow distinct band(s) that
represent α2-macroglobulin. B, Dogs with B. canis infection have significantly larger HDL diameter compared with control dogs (*P = .04), with no
difference in TRL diameter. Boxes indicate the lower to upper quartile (25th-75th percentile) and median value. Whiskers extend to minimum and
maximum values, with outliers shown as individual points
F IGURE 5 Relative apolipoprotein A-1 (ApoA-1) concentrations
in dogs with Babesia canis infection and in control dogs (*P = .02).
Boxes indicate the lower to upper quartile (25th-75th percentile) and
median value. Whiskers extend to minimum and maximum values
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consequence of its increased synthesis or decreased catabolism by
the kidneys.42 Necrosis of renal tubular epithelial cells occurs in fatal
cases of B. canis infection,43 but all infected dogs in the present study
recovered. Additional studies of altered renal catabolism and other
potential mechanisms of increased ApoA-1 in dogs with B. canis infec-
tion and the APR are warranted.
In dogs with B. canis-induced APR in this study, serum concentrations
of triglycerides and TRL did not differ from those in control dogs. In con-
trast, humans and rodents administered lipopolysaccharide (LPS) develop
hypertriglyceridemia as a result of increased production (with low-dose
LPS) or decreased clearance (with high-dose LPS) of VLDL particles.44 In
our study, dogs were anorexic for at least 24 to 48 hours before presen-
tation, which may have lowered triglyceride and TRL levels. Short-term
fasting (36 hours) induces a decrease in TRL in healthy dogs,45 raising the
possibility that any increase in VLDLs caused by inflammation might have
been masked, as has been described for primates and rodents.1 In previ-
ous studies, serum triglycerides concentration in dogs was increased after
the treatment of B. canis infection, suggesting the involvement of this
class of lipids in the APR.12 This reaction is proposed to be beneficial as
triglycerides are a source of fatty acids and a part of the innate defense
system that neutralizes lipophilic toxins.1
5 | LIMITATIONS
Although all the dogs had a noncomplicated form of B. canis infection
without autoimmune hemolytic anemia, acute renal failure, and septic
shock and marked APR, natural infections are heterogeneous, and the
variable amount of time between infection and presentation might have
differentially affected lipoprotein changes in infected dogs. Because all
dogs survived and recovered, we were unable to test the association
between severity of disease or prognosis and lipid and lipoprotein vari-
ables. Also, although concurrent vector-borne infections were excluded
using the SNAP 4Dx Plus test, we cannot rule out the presence of infec-
tious agents for which testing was not done. Potential comorbidities
such as chronic kidney disease also were not ruled out and could have
influenced the results. Although a relatively small number of dogs were
tested in this study, the population comprised all dogs meeting the
inclusion criteria within the designated B. canis tick season.
6 | CONCLUSION
Major changes associated with B. canis-induced APR in dogs are related
to concentration, composition, and morphology of HDL particles pointing
to an altered reverse cholesterol transport. Parallel ApoA-1 and SAA con-
centration increase is a unique still unexplained pathophysiological finding
that warrants further assessment of the prognostic significance.
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